Name: Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
Type: Benzodiazepine
AKA: Etodesnitazene; etazene
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
III. Chemical Profile (IUPAC name)
|
IV. History
Etizolam, a thienodiazepine, was first developed in the 1980s. It was introduced as an anxiolytic and hypnotic medication, offering similar effects to benzodiazepines but with a different chemical structure. The compound gained popularity in various countries for its effectiveness in treating anxiety and sleep disorders. Etizolam's use has been subject to regulatory controls due to dependence potential.
|
V. Legal Information
Etizolam is a thienodiazepine with anxiolytic properties. It is controlled in several countries due to its potential for abuse and dependence. In the United States, it is not specifically scheduled but is regulated under broader benzodiazepine controls. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
Etizolam is a benzodiazepine with anxiolytic and sedative properties. It causes sedation and muscle relaxation, acting as a downer. Short-term use is effective for managing anxiety and insomnia, while long-term use can lead to dependence and cognitive issues. Overdose risks include severe sedation and respiratory depression. Safe use involves following prescribed dosages and regular medical supervision. Recent research highlights its effectiveness in treating anxiety and its safety profile. |
VII. Psychological Effects
Etizolam, a thienodiazepine, provides sedation and anxiety relief. Immediate effects include reduced anxiety and mood stabilization. Long-term use may lead to dependence, tolerance, and cognitive impairments. Chronic use is associated with mood disorders and potential addiction. Recent research highlights its effectiveness in treating anxiety but also emphasizes the risks of long-term use and cognitive effects.
|
VIII. Culture
Etizolam is a thienodiazepine with anxiolytic and sedative properties, classifying it as a downer. Short-term use reduces anxiety and induces sleep, while long-term use can lead to dependence and withdrawal symptoms. Overdose risks include severe respiratory depression and potentially fatal outcomes. Safe dosages are medically prescribed, typically under 3 mg per day. Recent research highlights its efficacy in anxiety and insomnia management but warns of addiction risks. Physical effects include drowsiness, dizziness, and impaired coordination.
|